Steroid-Free Versus Steroid-Based Immunosuppression in Pediatric Renal (Kidney) Transplantation
Public ClinicalTrials.gov record NCT00141037. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Randomized, Multi-Center Comparative Trial of Tacrolimus w/Steroids and Standard Daclizumab Induction vs a Novel Steroid-Free Tacrolimus Based Immunosuppression Protocol w/ Extended Daclizumab Induction in Pediatric Renal Transplantation
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Over the last 40 years, corticosteroids (steroids) have been an important part of drug regimens used to prevent organ rejection and to maintain the immune health of individuals who have received organ transplants. Unfortunately, the negative physical effects of steroids can be severe, especially in children. The purpose of this study is to determine the safety and effectiveness of a steroid-free treatment regimen for children and adolescents who have received kidney (renal) transplants.
Study identification
- NCT ID
- NCT00141037
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Enrollment
- 130 participants
Conditions and interventions
Conditions
Interventions
- Daclizumab Drug
- Mycophenolate mofetil (MMF) Drug
- Prednisone Drug
- Tacrolimus Drug
- Ganciclovir Drug
- Valganciclovir Drug
- Trimethoprim and sulfamethoxazole Drug
Drug
Eligibility (public fields only)
- Age range
- Up to 21 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 2004 (Type not available)
- Primary completion
- Sep 2006 (Actual)
- Completion
- Nov 2010 (Actual)
- Last update posted
- Nov 29, 2016
2004 – 2010
United States locations
- U.S. sites
- 12
- U.S. states
- 9
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama - Pediatric Nephrology | Birmingham | Alabama | 35233 | — |
| Maxine Dunitz Children's Health Center Cedars-Sinai | Los Angeles | California | 90048 | — |
| UCLA - Department of Pediatrics, Division of Nephrology | Los Angeles | California | 90095-1752 | — |
| Stanford University Medical Center, Lucile Packard Children's Hospital | Palo Alto | California | 94304 | — |
| UCSF Children's Hospital | San Francisco | California | 94143 | — |
| University of Florida - Pediatric Nephrology | Gainesville | Florida | 32610-0296 | — |
| Children's Hospital of New Orleans-Department of Pediatric Nephrology | New Orleans | Louisiana | 70118 | — |
| Children's Hospital Boston - Division of Nephrology | Boston | Massachusetts | 02115 | — |
| University of Michigan Medical Center, C.S. Mott Children's Hospital- Division of Nephrology & Transplantation | Ann Arbor | Michigan | 48109 | — |
| Children's Mercy Hospital - Department of Nephrology | Kansas City | Missouri | 64108 | — |
| The Children's Hospital of Philadelphia-Department of Nephrology | Philadelphia | Pennsylvania | 19104 | — |
| Children's Hospital & Regional Medical Center - Division of Nephrology | Seattle | Washington | 98105 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00141037, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 29, 2016 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00141037 live on ClinicalTrials.gov.